Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NutraMax Products

This article was originally published in The Tan Sheet

Executive Summary

Gloucester, Mass.-based firm introduced national brand equivalent to Halls Fruit Breezers and Band-Aid bandages at Private Labelers Manufacturers Association show in Chicago in November 2003. "The Tan Sheet" reported Nov. 24, 2003 (1p. 15) that Edgewood, Md.-based Nutramax Laboratories was responsible for the launch...

You may also be interested in...

PLMA In Brief

Perrigo predictor: Private label firm unveils its Easy Ovulation Predictor, equivalent to Inverness Medical Innovations' Clearblue Easy, at the Private Label Manufacturers Association trade show Nov. 16-18 in Chicago. The seven-test kit will ship in January. Perrigo also launched adult low-strength aspirin, a national brand equivalent (NBE) to McNeil Consumer & Specialty Pharmaceutical's St. Joseph's. The 81 mg coated tablets come in a 180-count bottle. Separately, the Allegan, Mich.-based firm received approval this month for a product comparable to Aleve Cold & Sinus...

USP Nitrosamine Impurities Chapter Reflects Careful Coordination With US, EU Authorities

The USP’s general chapter on nitrosamine impurities provides guidance on assessing risks and testing levels of the carcinogens in pharmaceuticals.

ASH Preview: Three Areas To Watch In Hematology-Oncology

Novartis hopes a CAR-T with rapid manufacturing will be a winner, while novel bispecific antibodies in lymphoma and myeloma will make appearances, along with next-generation PI3K and BTK inhibitors.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts